OKYO Pharma Ltd - OKYO

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$9.725M
QoQ value delta ($000)
-$7K (-0.07%)
Implied price effect (QoQ)
-0.07%
Shares
Total shares
6,493,709
QoQ shares delta
-2 (0.0%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (OKYO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Woodline Partners LP 5,479 3,652,768 0.02%
Stonepine Capital Management, LLC 1,294 862,996 0.73%
Maven Securities LTD 1,213 809,317 0.02%
BALYASNY ASSET MANAGEMENT L.P. 870 580,596 0.0%
Opaleye Management Inc. 562 375,204 0.05%
UBS Group AG 82 55,009 0.0%
XTX Topco Ltd 56 37,769 0.0%
Quantinno Capital Management LP 49 33,255 0.0%
CHOREO, LLC 42 33,255 0.0%
Cerity Partners LLC 19 12,812 0.0%
GEODE CAPITAL MANAGEMENT, LLC 18 12,090 0.0%
RENAISSANCE TECHNOLOGIES LLC 16 11,200 0.0%
JANE STREET GROUP, LLC 15 10,302 0.0%
Steward Partners Investment Advisory, LLC 9 6,000 0.0%
EFG International AG 1 923 0.0%
MORGAN STANLEY 0 10 0.0%
OSAIC HOLDINGS, INC. 0 152 0.0%
Continuum Advisory, LLC 0 50 0.0%
Caitong International Asset Management Co., Ltd 0 1 0.0%